Yeramian Patrick D
- SEC CIK
- 0001358266
No open-market purchases or sales filed in the past year.
Current role at each company
- AMLX Amylyx Pharmaceuticals, Inc.Chief Medical Officeras of Jan 11, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Yeramian Patrick D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 11, 2024 (view filing) | Jan 9 | 2 days | Yeramian Patrick DChief Medical Officer | SSale | −2.81K | $16.33 | −$45.9K | −1.3%205.6K after | |
| May 17, 2023 (view filing)4:58 PM ET | May 15 | 2 days | Yeramian Patrick DChief Medical Officer | SSale | −12.0K | $29.03 | −$347.4K | −5.4%208.4K after | 10b5-1 |
| Apr 19, 2023 (view filing)7:45 PM ET | Apr 17 | 2 days | Yeramian Patrick DChief Medical Officer | SSale | −49.6K | $30.54 | −$1.51M | −19.2%208.4K after | 2 lots10b5-1 |
| Mar 24, 2023 (view filing)6:45 PM ET | Mar 16 | 8 days | Yeramian Patrick DChief Medical Officer | SSale | −54.6K | $31.87 | −$1.74M | −21.5%199.3K after | Amended2 lots |
| Jan 10, 2023 (view filing) | Jan 6 | 4 days | Yeramian Patrick DChief Medical Officer | SSale | +2.03K | $36.30 | +$73.8K | +1.0%204.3K after | 2 lots |